×

Prestige Consumer Healthcare Free Cash Flow 2010-2024 | PBH

Prestige Consumer Healthcare free cash flow from 2010 to 2024. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
Prestige Consumer Healthcare Annual Free Cash Flow
2024 239.38
2023 221.93
2022 250.28
2021 213.36
2020 202.56
2019 178.80
2018 197.58
2017 145.78
2016 173.09
2015 160.15
2014 108.82
2013 127.35
2012 66.85
2011 86.03
2010 58.75
2009 66.20
Prestige Consumer Healthcare Quarterly Free Cash Flow
2024-09-30 121.40
2024-06-30 53.62
2024-03-31 239.38
2023-12-31 175.61
2023-09-30 106.14
2023-06-30 46.61
2023-03-31 221.93
2022-12-31 165.50
2022-09-30 112.36
2022-06-30 57.20
2022-03-31 250.28
2021-12-31 190.32
2021-09-30 126.25
2021-06-30 67.81
2021-03-31 213.36
2020-12-31 159.17
2020-09-30 115.67
2020-06-30 72.60
2020-03-31 202.56
2019-12-31 151.94
2019-09-30 97.18
2019-06-30 50.82
2019-03-31 178.80
2018-12-31 131.30
2018-09-30 90.03
2018-06-30 53.38
2018-03-31 197.58
2017-12-31 146.02
2017-09-30 103.76
2017-06-30 51.57
2017-03-31 145.78
2016-12-31 139.30
2016-09-30 99.75
2016-06-30 50.41
2016-03-31 173.09
2015-12-31 134.26
2015-09-30 89.25
2015-06-30 43.09
2015-03-31 160.15
2014-12-31 110.44
2014-09-30 55.68
2014-06-30 29.18
2014-03-31 108.82
2013-12-31 78.21
2013-09-30 53.28
2013-06-30 21.44
2013-03-31 127.35
2012-12-31 91.97
2012-09-30 55.12
2012-06-30 13.56
2012-03-31 66.85
2011-12-31 47.64
2011-09-30 33.16
2011-06-30 15.37
2011-03-31 86.03
2010-12-31 61.25
2010-09-30 42.56
2010-06-30 20.58
2010-03-31 58.75
2009-12-31 50.09
2009-09-30 39.65
2009-06-30 17.97
2009-03-31 66.20
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $3.823B $1.125B
Prestige Consumer Healthcare Inc. is a consumer healthcare products company. Its diverse portfolio of brands include Monistat(R) and Summer's Eve(R) women's health products, BC(R) and Goody's(R) pain relievers, Clear Eyes(R) and TheraTears(R) eye care products, DenTek(R) specialty oral care products, Dramamine(R) motion sickness treatments, Fleet(R) enemas and glycerin suppositories, Chloraseptic(R) and Luden's(R) sore throat treatments and drops, Compound W(R) wart treatments, Little Remedies(R) pediatric over-the-counter products, Boudreaux's Butt Paste(R) diaper rash ointments, Nix(R) lice treatment, Debrox(R) earwax remover, Gaviscon(R) antacid in Canada, and Hydralyte(R) rehydration products and the Fess(R) line of nasal and sinus care products in Australia. Prestige Consumer Healthcare Inc., formerly known as Prestige Brands Holdings Inc., is based in Tarrytown, New York.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $204.284B 25.22
Stryker (SYK) United States $148.861B 33.55
Boston Scientific (BSX) United States $147.840B 42.50
EssilorLuxottica (ESLOY) France $120.398B 0.00
Medtronic (MDT) Ireland $112.636B 16.73
Lonza Group Ag (LZAGY) Switzerland $46.153B 0.00
Haleon (HLN) United Kingdom $41.736B 27.12
GE HealthCare Technologies (GEHC) United States $39.899B 20.69
ResMed (RMD) United States $36.307B 29.83
Terumo (TRUMY) Japan $28.860B 40.76
Koninklijke Philips (PHG) Netherlands $24.692B 18.90
Zimmer Biomet Holdings (ZBH) United States $21.842B 13.91
Insulet (PODD) United States $19.563B 77.90
Baxter (BAX) United States $16.252B 10.57
Smith & Nephew SNATS (SNN) United Kingdom $11.030B 0.00
Bio-Rad Laboratories (BIO) United States $10.094B 34.30
BellRing Brands (BRBR) United States $9.817B 39.50
Demant (WILYY) Denmark $8.735B 0.00
Lantheus Holdings (LNTH) United States $6.632B 15.41
ICU Medical (ICUI) United States $4.089B 38.93
Haemonetics (HAE) United States $3.684B 17.98
Envista Holdings (NVST) United States $3.623B 26.99
Perrigo (PRGO) Ireland $3.281B 9.66
Shandong Weigao Medical Polymer (SHWGF) China $3.010B 0.00
QuidelOrtho (QDEL) United States $2.992B 19.25
GN Store Nord (GNNDY) Denmark $2.797B 17.94
Neogen (NEOG) United States $2.592B 29.88
LeMaitre Vascular (LMAT) United States $2.203B 53.55
AtriCure (ATRC) United States $1.926B 0.00
Green Thumb Industries (GTBIF) United States $1.514B 26.50
InMode (INMD) Israel $1.434B 8.62
AdaptHealth (AHCO) United States $1.368B 9.78
Maravai LifeSciences Holdings (MRVI) United States $1.343B 0.00
BioLife Solutions (BLFS) United States $1.274B 0.00
Owens & Minor (OMI) United States $1.145B 8.95
Curaleaf Holdings (CURLF) Canada $0.903B 0.00
Evolus (EOLS) United States $0.895B 0.00
Phibro Animal Health (PAHC) United States $0.881B 15.54
CeriBell (CBLL) United States $0.833B 0.00
Capricor Therapeutics (CAPR) United States $0.678B 0.00
VAREX IMAGING (VREX) United States $0.572B 25.24
Omeros (OMER) United States $0.538B 0.00
Surmodics (SRDX) United States $0.530B 0.00
Cresco Labs (CRLBF) United States $0.434B 0.00
Verano Holdings (VRNOF) United States $0.418B 0.00
ZimVie (ZIMV) United States $0.391B 32.91
Quanterix (QTRX) United States $0.386B 0.00
Valneva SE (VALN) France $0.376B 0.00
Cerus (CERS) United States $0.336B 0.00
Sanara MedTech (SMTI) United States $0.330B 0.00
Viemed Healthcare (VMD) United States $0.317B 30.11
Biote (BTMD) United States $0.307B 6.73
OraSure Technologies (OSUR) United States $0.290B 19.45
Canopy Growth (CGC) Canada $0.263B 0.00
Zynex (ZYXI) United States $0.261B 54.53
High Tide (HITI) Canada $0.244B 100.33
Sanuwave Health (SNWV) United States $0.233B 3.28
Utah Medical Products (UTMD) United States $0.213B 14.71
Aurora Cannabis (ACB) Canada $0.212B 0.00
Brainsway (BWAY) Israel $0.208B 110.50
Organigram Holdings (OGI) Canada $0.198B 0.00
MacroGenics (MGNX) United States $0.193B 0.00
TerrAscend (TSNDF) Canada $0.153B 0.00
Veru (VERU) United States $0.152B 0.00
TriSalus Life Sciences (TLSI) United States $0.149B 0.00
FitLife Brands (FTLF) United States $0.145B 18.29
Jin Medical (ZJYL) China $0.136B 0.00
Quipt Home Medical (QIPT) United States $0.127B 0.00
Fonar (FONR) United States $0.097B 11.00
Oramed Pharmaceuticals (ORMP) United States $0.093B 0.00
InterCure (INCR) Israel $0.078B 0.00
INLIF (INLF) $0.074B 0.00
Exagen (XGN) United States $0.071B 0.00
Rockwell Medical (RMTI) United States $0.070B 36.33
Apyx Medical (APYX) United States $0.057B 0.00
Jushi Holdings (JUSHF) United States $0.057B 0.00
Cytosorbents (CTSO) United States $0.056B 0.00
ImmuCell (ICCC) United States $0.046B 0.00
Modular Medical (MODD) United States $0.043B 0.00
Safety Shot (SHOT) United States $0.029B 0.00
Nephros (NEPH) United States $0.017B 0.00
Innovative Eyewear (LUCY) United States $0.015B 0.00
Flora Growth (FLGC) United States $0.013B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
Allurion Technologies (ALUR) United States $0.008B 0.00
Meihua Medical Technologies (MHUA) China $0.008B 0.00
Trinity Biotech (TRIB) Ireland $0.006B 0.00
Agape ATP (ATPC) $0.006B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
Sharps Technology (STSS) United States $0.004B 0.00
Senestech (SNES) United States $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
GlucoTrack (GCTK) United States $0.002B 0.00
United-Guardian (UG) United States $0.000B 14.07
SNDL (SNDL) Canada $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00